GlassScriptPhysician profile
James Arthur Sotrop
NPI 1740248384
$8,158.94
in general payments reported to CMS, 2019-2025
37 companies · $990 in 2025
The $990 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $1,374 · 2021: $1,302 · 2022: $947 · 2023: $1,086 · 2024: $1,361 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,380 · Education: $56.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,379.94 |
| Education | $56.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,681.36 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,303.22 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $1,234.45 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $890.38 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $746.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $505.68 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $324.12 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.46 | 2022-2025 | |
| Glaxosmithkline, LLC. | $155.68 | 2020-2025 | Shingrix, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.83 | 2019 | |
| Inari Medical, INC. | $91.00 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Idorsia Pharmaceuticals US INC | $83.75 | 2022-2024 | Quviviq |
| Exact Sciences Corporation | $82.70 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $70.56 | 2022-2024 | Freestyle Libre 3 |
| Almatica Pharma LLC | $62.40 | 2021-2024 | Loreev Xr |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sotrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.